ResMed Aktie
| 241,58USD | 3,39USD | 1,42% |
WKN DE: 895878 / ISIN: US7611521078
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,22 |
| The Vanguard Group, Inc. | 12,59 |
| Vanguard Group, Inc. (Subfiler) | 11,83 |
| State Street Corp. | 4,27 |
| BlackRock Fund Advisors | 3,82 |
| Walter Scott & Partners Ltd. | 3,17 |
| Vanguard Total Stock Market ETF | 3,17 |
| Geode Capital Management LLC | 2,63 |
| Vanguard 500 Index Fund | 2,62 |
| WCM Investment Management LLC | 2,39 |
| BlackRock Institutional Trust Co. NA | 2,18 |
| Vanguard Mid Cap Index Fund | 2,12 |
| Morgan Stanley Capital Services LLC | 2,09 |
| Fidelity 500 Index Fund | 1,23 |
| SPDR S&P 500 ETF Trust | 1,21 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 7 770 | 7 970 | 8 160 | 10 140 | 9 980 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,38 | 0,40 | 0,44 | 0,42 | 0,47 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 1 523 | 1 575 | 1 931 | 2 368 | 2 358 |
| Summe Anlagevermögen | 3 064 | 3 153 | 3 164 | 4 384 | 4 515 |
| Summe Aktiva | 4 587 | 4 728 | 5 096 | 6 752 | 6 872 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 1 299 | 794 | 918 | 1 580 | 874 |
| Summe Fremdkapital | 2 090 | 1 842 | 1 735 | 2 622 | 2 008 |
| Summe Eigenkapital | 2 497 | 2 886 | 3 361 | 4 130 | 4 864 |
| Summe Passiva | 4 587 | 4 728 | 5 096 | 6 752 | 6 872 |
Adresse
| 9001 Spectrum Center Boulevard, 92123 San Diego | |
| Telefon | +1 (858) 836-5000 |
| Internet | http://www.resmed.com |
Management
|
Alastair Robertson
Chief Information Officer |
|
Amy Wakeham
Chief Investor Relations Officer |
|
Andrew Price
Chief Supply Chain Officer |
|
Bobby Ghoshal
Chief Commercial Officer-SaaS |
|
Brett A. Sandercock
Chief Financial Officer |
|
Carlos M. Nunez
Chief Medical Officer |
|
Carol J. Burt
Independent Director |
|
Christopher J. DelOrefice
Independent Director |
|
Dawn Haake
Chief Quality Officer |
|
Desney Tan
Independent Director |
|
Geoff Neilson
Senior Vice President-Global Supplier Alliance |
|
Harjit Gill
Independent Director |
|
Hemanth Reddy
Chief Strategy Officer |
|
Jan D. de Witte
Independent Director |
|
Jim Ellis
Chief Compliance Officer |
|
John B. Hernandez
Independent Director |
|
Justin G. Leong
Chief Product Officer |
|
Karen Ruth Drexler
Independent Director |
|
Lucile Blaise
Senior VP-Strategy & Business Development |
|
Michael Fliss
Chief Revenue Officer |
|
Michael J. Farrell
Chairman & Chief Executive Officer |
|
Michael Rider
Secretary & Chief Legal Officer |
|
Peter C. Farrell
Chairman-Emeritus |
|
Richard Sulpizio
Independent Director |
|
Ronald R. Taylor
Lead Independent Director |
|
Shane Azzi
Chief Supply Chain Officer |
|
Todd Friedman
Chief Information Security Officer |
|
Vered Keisar
Chief People Officer |
|
Yvonne-Katrin Pucknat
Chief Marketing Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
